- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: Arcapta Neohaler® | Onbrez® | QAB-149 | QAB149
indacaterol is an approved drug (EMA (2009), FDA (2011))
Compound class: Synthetic organic
Comment: Only the R-enantiomer, as the maleate salt (PubChem CID 9827599) is contained in the medicinal product.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
View more information in the IUPHAR Pharmacology Education Project: indacaterol
1. Beattie D, Beer D, Bradley ME, Bruce I, Charlton SJ, Cuenoud BM, Fairhurst RA, Farr D, Fozard JR, Janus D et al.. (2012)
An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol.
Bioorg Med Chem Lett, 22 (19): 6280-5. [PMID:22932315]
2. Cazzola M, Matera MG, Lötvall J. (2005)
Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease.
Expert Opin Investig Drugs, 14 (7): 775-83. [PMID:16022567]